Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study.
- DOI
- 10.1093/ecco-jcc/jjaf138
- Published
- 2025 Sep 7
- Container
- Journal of Crohn's & colitis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjaf138,
title = {Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study.},
author = {Loftus EV Jr and D'Haens G and Louis E and Regueiro M and Jairath V and Magro F and Nakase H and Dubcenco E and Lacerda AP and Ford S and Feng T and Duncan B and Fish I and Cunneen C and Anyanwu SI and Aponte F and Griffith J and Blumenstein I},
year = {2025},
journal = {Journal of Crohn's \& colitis},
doi = {10.1093/ecco-jcc/jjaf138},
url = {https://doi.org/10.1093/ecco-jcc/jjaf138}
}RIS
TY - JOUR TI - Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study. AU - Loftus EV Jr AU - D'Haens G AU - Louis E AU - Regueiro M AU - Jairath V AU - Magro F AU - Nakase H AU - Dubcenco E AU - Lacerda AP AU - Ford S AU - Feng T AU - Duncan B AU - Fish I AU - Cunneen C AU - Anyanwu SI AU - Aponte F AU - Griffith J AU - Blumenstein I PY - 2025 JO - Journal of Crohn's & colitis DO - 10.1093/ecco-jcc/jjaf138 UR - https://doi.org/10.1093/ecco-jcc/jjaf138 ER -
APA
Jr, L. E., G, D., E, L., M, R., V, J., F, M., H, N., E, D., AP, L., S, F., T, F., B, D., I, F., C, C., SI, A., F, A., J, G., & I, B. (2025). Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjaf138
Source records
- pubmed · retrieved 2026-09-27T10:14:38.663Z
- europe-pmc · retrieved 2026-09-27T10:14:38.669Z